Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

I.V. Bijnsdorp, F.A.E. Kruyt, M Fukushima, K Smid, S. Gokoel, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

34 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)440-447
JournalCancer Science
Volume101
Issue number2
DOIs
Publication statusPublished - 2010

Cite this

@article{21e83b1d61114adb9d89485858c8b755,
title = "Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines",
author = "I.V. Bijnsdorp and F.A.E. Kruyt and M Fukushima and K Smid and S. Gokoel and G.J. Peters",
year = "2010",
doi = "10.1111/j.1349-7006.2009.01375.x",
language = "Undefined/Unknown",
volume = "101",
pages = "440--447",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "2",

}

Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines. / Bijnsdorp, I.V.; Kruyt, F.A.E.; Fukushima, M; Smid, K; Gokoel, S.; Peters, G.J.

In: Cancer Science, Vol. 101, No. 2, 2010, p. 440-447.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Molecular mechanism underlying the synergistic interaction between trifluorothymidine and the epidermal growth factor receptor inhibitor erlotinib in human colorectal cancer cell lines

AU - Bijnsdorp, I.V.

AU - Kruyt, F.A.E.

AU - Fukushima, M

AU - Smid, K

AU - Gokoel, S.

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - 10.1111/j.1349-7006.2009.01375.x

DO - 10.1111/j.1349-7006.2009.01375.x

M3 - Article

VL - 101

SP - 440

EP - 447

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 2

ER -